Role of low dose capecitabine and erlotinib in treatment of recurrent or metastatic head and neck cancer.

Authors: Abdul Mateen, Muhammad Hasan Mateen, Allah Rakha Adil, Famya Abdullah

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18003

Source: Full article


Abstract

e18003